Invention Grant
- Patent Title: Ghrelin binding nucleic acids
- Patent Title (中): 生长素释放肽结合核酸
-
Application No.: US10522582Application Date: 2003-08-01
-
Publication No.: US07750140B2Publication Date: 2010-07-06
- Inventor: Steffen Helmling , Dirk Eulberg , Christian Maasch , Sven Klussmann
- Applicant: Steffen Helmling , Dirk Eulberg , Christian Maasch , Sven Klussmann
- Applicant Address: DE Berlin
- Assignee: NOXXON Pharma AG
- Current Assignee: NOXXON Pharma AG
- Current Assignee Address: DE Berlin
- Agency: MDIP LLC
- Priority: EP02017317 20020801; EP02023637 20021019; EP03014111 20030623
- International Application: PCT/EP03/08542 WO 20030801
- International Announcement: WO2004/013274 WO 20040212
- Main IPC: C07H21/04
- IPC: C07H21/04 ; A61K31/70
Abstract:
The present invention is related to an antagonist of ghrelin, wherein the antagonist is a nucleic acid, and whereby preferably the nucleic acid is binding to ghrelin.
Public/Granted literature
- US20060257867A1 Ghrelin binding nucleic acids Public/Granted day:2006-11-16
Information query
